Lars Linden

Person

Dusseldorf, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Radio-pharmaceutical complexes
- Patent number 11,260,136
- Issue date Mar 1, 2022
- Bayer Pharma Aktiengesellschaft
- Lars Linden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Epitope of optimized humanized monoclonal antibodies against activa...
- Patent number 11,077,187
- Issue date Aug 3, 2021
- Oklahoma Medical Research Foundation
- Xiao-Yan Zhao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neutralizing prolactin receptor antibody Mat3 and its therapeutic use
- Patent number 9,777,063
- Issue date Oct 3, 2017
- Bayer Intellectual Property GmbH
- Christoph Freiberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Relaxin fusion polypeptides and uses thereof
- Patent number 9,382,305
- Issue date Jul 5, 2016
- Bayer Intellectual Property GmbH
- Andreas Wilmen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neutralizing prolactin receptor antibody Mat3 and its therapeutic use
- Patent number 9,353,186
- Issue date May 31, 2016
- Bayer Intellectual Property GmbH
- Christoph Freiberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Binder-drug conjugates (ADCs) and use thereof
- Patent number 8,992,932
- Issue date Mar 31, 2015
- Seattle Genetics, Inc.
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
RADIO-PHARMACEUTICAL COMPLEXES
- Publication number 20220143229
- Publication date May 12, 2022
- BAYER PHARMA AKTIENGESELLSCHAFT
- Lars LINDEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RADIO-PHARMACEUTICAL COMPLEXES
- Publication number 20190091354
- Publication date Mar 28, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- Lars LINDEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EPITOPE OF OPTIMIZED HUMANIZED MONOCLONAL ANTIBODIES AGAINST ACTIVA...
- Publication number 20180326053
- Publication date Nov 15, 2018
- Bayer HealthCare, LLC
- Xiao-Yan ZHAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-C4.4A ANTIBODIES AND USES THEREOF
- Publication number 20170158775
- Publication date Jun 8, 2017
- Bayer Intellectual Property GmbH
- Lars Linden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUTRALIZING PROLACTIN RECEPTOR ANTIBODY MAT3 AND ITS THERAPEUTIC USE
- Publication number 20160319029
- Publication date Nov 3, 2016
- Bayer Intellectual Property GmbH
- Christoph Freiberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-TWEAKR ANTIBODIES AND USES THEREOF
- Publication number 20160237160
- Publication date Aug 18, 2016
- BAYER PHARMA AKTIENGESELLSCHAFT
- Christian VOTSMEIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEW BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF
- Publication number 20160193359
- Publication date Jul 7, 2016
- Seattle Genetics, Inc.
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PDGFRBETA-FC FUSION PROTEINS AND USES THEREOF
- Publication number 20160009776
- Publication date Jan 14, 2016
- BAYER PHARMA AKTIENGESELLSCHAFT
- Lars Linden
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL BINDER-DRUG CONJUGATES (ADCs) AND USE OF SAME
- Publication number 20150246136
- Publication date Sep 3, 2015
- Seattle Genetics, Inc.
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF
- Publication number 20150030618
- Publication date Jan 29, 2015
- Seattle Genetics, Inc.
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-FGFR2 Antibodies and Uses Thereof
- Publication number 20140322220
- Publication date Oct 30, 2014
- Bayer Intellectual Property GmbH
- Axel Harrenga
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RELAXIN FUSION POLYPEPTIDES AND USES THEREOF
- Publication number 20140187491
- Publication date Jul 3, 2014
- Bayer Intellectual Property GmbH
- Andreas Wilmen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUTRALIZING PROLACTIN RECEPTOR ANTIBODY MAT3 AND ITS THERAPEUTIC USE
- Publication number 20140141003
- Publication date May 22, 2014
- Bayer Intellectual Property GmbH
- Christoph Freiberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel Binder-Drug Conjugates (ADCs) and Use of Same
- Publication number 20140127240
- Publication date May 8, 2014
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BINDING PROTEINS TO INHIBITORS OF COAGULATION FACTORS
- Publication number 20140050743
- Publication date Feb 20, 2014
- Bayer Intellectual Property GmbH
- Frank Dittmer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEW BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF
- Publication number 20130122024
- Publication date May 16, 2013
- Bayer Intellectual Property GmbH
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
New binder-drug conjugates (ADCs) and use thereof
- Publication number 20130095123
- Publication date Apr 18, 2013
- Seattle Genetics, Inc.
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEW BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF
- Publication number 20130066055
- Publication date Mar 14, 2013
- Bayer Intellectual Property GmbH
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-C4.4A ANTIBODIES AND USES THEREOF
- Publication number 20120321619
- Publication date Dec 20, 2012
- Bayer Intellectual Property GmbH
- Lars Linden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Lars Linden

Person

Patents Grantslast 30 patents

Radio-pharmaceutical complexes

Epitope of optimized humanized monoclonal antibodies against activa...

Neutralizing prolactin receptor antibody Mat3 and its therapeutic use

Relaxin fusion polypeptides and uses thereof

Neutralizing prolactin receptor antibody Mat3 and its therapeutic use

Binder-drug conjugates (ADCs) and use thereof

Patents Applicationslast 30 patents

RADIO-PHARMACEUTICAL COMPLEXES

RADIO-PHARMACEUTICAL COMPLEXES

EPITOPE OF OPTIMIZED HUMANIZED MONOCLONAL ANTIBODIES AGAINST ACTIVA...

ANTI-C4.4A ANTIBODIES AND USES THEREOF

NEUTRALIZING PROLACTIN RECEPTOR ANTIBODY MAT3 AND ITS THERAPEUTIC USE

ANTI-TWEAKR ANTIBODIES AND USES THEREOF

NEW BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF

PDGFRBETA-FC FUSION PROTEINS AND USES THEREOF

NOVEL BINDER-DRUG CONJUGATES (ADCs) AND USE OF SAME

NOVEL BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF

Anti-FGFR2 Antibodies and Uses Thereof

RELAXIN FUSION POLYPEPTIDES AND USES THEREOF

NEUTRALIZING PROLACTIN RECEPTOR ANTIBODY MAT3 AND ITS THERAPEUTIC USE

Novel Binder-Drug Conjugates (ADCs) and Use of Same

BINDING PROTEINS TO INHIBITORS OF COAGULATION FACTORS

NEW BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF

New binder-drug conjugates (ADCs) and use thereof

NEW BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF

ANTI-C4.4A ANTIBODIES AND USES THEREOF